Improving Cardiac Rehabilitation Participation in Women and Men
NCT ID: NCT00336830
Last Updated: 2014-03-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
1035 participants
INTERVENTIONAL
2003-05-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of an Introductory Videotape Intervention to Improve Cardiac Rehabilitation Participation
NCT00372671
Cardiac Rehabilitation Peer Mentorship
NCT02204449
The Efficacy and Economics of Exercise Maintenance Post-Cardiac Rehabilitation
NCT01658683
The Effect of Cardiac Rehabilitation on Left Ventricular Remodeling in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction
NCT07155928
Adapted Cardiac Rehabilitation After Stroke
NCT01067495
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual Care
Comparator without MD endorsement of Cardiac Rehabilitation
Standard Cardiac Rehabilitation referral
Note to patient with general description of the Cardiac Rehabilitation program without signature or recommendation from attending physician.
MD Endorsment of CR
Provided with MD endorsement of participation in Cardiac Rehabilitation
MD-endorsed Cardiac Rehabilitation referral
Note to patient with general description of the Cardiac Rehabilitation program with signature and strong recommendation from attending physician.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MD-endorsed Cardiac Rehabilitation referral
Note to patient with general description of the Cardiac Rehabilitation program with signature and strong recommendation from attending physician.
Standard Cardiac Rehabilitation referral
Note to patient with general description of the Cardiac Rehabilitation program without signature or recommendation from attending physician.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient resides within 1 hour driving time from London
Exclusion Criteria
* Previous cardiac rehabilitation participation
* Patient scheduled to undergo PTCA or CABS within two months following the index hospital discharge
* Inability to exercise due to musculoskeletal problems or previous or current stroke
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
AstraZeneca
INDUSTRY
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Neville Suskin
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Neville Suskin, MBChB, MSc
Role: PRINCIPAL_INVESTIGATOR
University of Western Ontario & London Health Sciences Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
London Health Sciences Centre
London, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIHR 56926
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
R-02-037
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.